Hello & Welcome

Dr. Ian Pinto

Specialty

Oncology

Qualification

MBBS ,MD , FAGE,Master’s in Public Health,D.M. (Hematology),D.M. (Medical Oncology) ,F.A.C.P.

experience

14 years

Research

  • 3/2017 Pinto IG. Systemic therapy in bladder cancer. Indian J Urol 2017;33:118-26
    (3); 208-16
  • 07/2014 Pinto et al Concurrent crizotinib and whole brain radiation for brain metastases in
    ALK positive lung adenocarcinoma. Lung Cancer Management (2014)3(5), 369-371
  • 04/2014 Adjuvant chemotherapy in the elderly with Non-small cell lung cancer
  • American Association for Cancer Research Annual Meeting (Abstract presentation)
  • 07/2015 Pinto et al A retrospective analysis ALK-positive non-small-cell lung carcinoma.
    European Journal of Cancer. July 2015. Volume 51, Supplement 2, Page e22.
  • 04/2015 Retrospective review of patients with ALK + Non-Small Cell Lung cancer. Oral and
    poster presentation at Asian Oncology Summit, Lancet Oncology, Shanghai, China.
  • 04/2015 Pinto et al New Oral Anticoagulants and their reversal. Current Drug Safety 2015; 10

Awards recogniation

  • Chief fellow, Hematology Oncology Fellowship Program, State University of New York, USA
  • Fellow of American College of Physicians (FACP), New York, USA
  • Housestaff Physician Leadership Award, New York, USA
  • President of Housestaff Physician Association, New York, USA
  • 2nd Prize for Research Presentation at Strong Hospital, University of Rochester
  • Scholarship Tagore Educational Society for highest score in Internal Medicine, Mumbai, India
  • Certificate of Honor from St. Luke’s Medical Guild for highest score in Final M.B.B.S., Mumbai,
    India

Professional Membership

  • American Society of Blood and Marrow Transplantation
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American College of Physicians
AllEscortAllEscort